Within the subgroup receiving AD regimen, CD44+/CD24− tumour cell proportions also increased significantly (P=0.017) and the grades of ALDH1+ tumour cells had a tendency to increase after PST (P=0.098). The gene discussed is ALDH1A1; the disease is neoplasm.